Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II
Status: | Recruiting |
---|---|
Conditions: | Lung Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 40 - Any |
Updated: | 2/28/2019 |
Start Date: | October 1, 2016 |
End Date: | September 30, 2020 |
Contact: | Lynn F Reinke, PhD ARNP |
Email: | lynn.reinke1@va.gov |
Phone: | (206) 277-4186 |
The focus of the study is to test a nurse-led telephone-based palliative care intervention on
improving the delivery of care for patients with newly diagnosed lung cancer. The study is a
three site randomized control trial to determine the efficacy of the intervention on
improving patients' quality of life, symptom burden, and satisfaction of care. Additionally,
the study will test an innovative care delivery model to improve patients' access to
palliative care. The investigators will also determine the effect of the intervention on
patient activation to discuss treatment preferences with their clinician and on clinician
knowledge of patients' goals of care.
improving the delivery of care for patients with newly diagnosed lung cancer. The study is a
three site randomized control trial to determine the efficacy of the intervention on
improving patients' quality of life, symptom burden, and satisfaction of care. Additionally,
the study will test an innovative care delivery model to improve patients' access to
palliative care. The investigators will also determine the effect of the intervention on
patient activation to discuss treatment preferences with their clinician and on clinician
knowledge of patients' goals of care.
Patients meeting entry criteria will be randomized to the intervention arm, palliative care
plus usual care, or the usual care arm. Patients randomized to the intervention arm will
receive usual oncologic care and phone calls from a nurse. Outcome measures will be collected
at baseline and at the end of the patients' primary cancer treatment. The study will be
performed at the Puget Sound Health Care System, Birmingham VA and Portland VA. The
investigators will recruit individuals (n=138) with lung cancer over 2.5 years. The primary
objective is to determine the efficacy of the nurse-led telephone-based palliative
intervention on improving patients' quality of life, symptom burden, and satisfaction of
care. In addition, using validated instruments, the investigators will assess the effect of
the intervention on patient activation to discuss treatment preferences with their clinician
and on clinician knowledge of patients' goals of care. The results of this study will inform
a future effectiveness/implementation study.
plus usual care, or the usual care arm. Patients randomized to the intervention arm will
receive usual oncologic care and phone calls from a nurse. Outcome measures will be collected
at baseline and at the end of the patients' primary cancer treatment. The study will be
performed at the Puget Sound Health Care System, Birmingham VA and Portland VA. The
investigators will recruit individuals (n=138) with lung cancer over 2.5 years. The primary
objective is to determine the efficacy of the nurse-led telephone-based palliative
intervention on improving patients' quality of life, symptom burden, and satisfaction of
care. In addition, using validated instruments, the investigators will assess the effect of
the intervention on patient activation to discuss treatment preferences with their clinician
and on clinician knowledge of patients' goals of care. The results of this study will inform
a future effectiveness/implementation study.
Inclusion Criteria:
Patients diagnosed at the Puget Sound Health Care System, Birmingham VA, or Portland VA
with a primary diagnosis of lung cancer that requires more than surgical resection:
- diagnosed within 8 weeks of recruitment
- must have telephone access
- ability to understand English
- able to participate in informed consent process
Exclusion Criteria:
Patients not eligible to participate in the study include those who are inpatients prior to
randomization,
- those who are under the care of palliative care or hospice at the time of
randomization
- those who have severe mental health disorders
- those who are unable to speak directly with the nurse over the telephone
- or those that have the inability to provide informed consent
We found this trial at
3
sites
Seattle, Washington 98108
Principal Investigator: Lynn F. Reinke, PhD ARNP
Phone: 206-277-4154
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials